BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bioinformatics Software | QIAGEN Digital Insights
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20220313T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20221106T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240221T090000
DTEND;TZID=America/New_York:20240221T100000
DTSTAMP:20260404T211905
CREATED:20240207T213516Z
LAST-MODIFIED:20241024T183019Z
UID:10000727-1708506000-1708509600@staging.digitalinsights.supremeclients.com
SUMMARY:How biopharmaceutical companies can leverage expert-curated knowledge from Wellcome Sanger Institute and QIAGEN to accelerate cancer drug discovery and development
DESCRIPTION:The cancer drug discovery landscape is shifting. While research continues to grow in cost and complexity\, the pace of development has never been faster. Biopharmaceutical companies can’t afford to waste time and resources pursuing ineffective or unsafe ideas. \nIn this talk\, our experts discuss how biopharmaceutical companies can leverage key genomic\, biomedical\, and clinical trial databases to improve and accelerate cancer drug discovery while avoiding potential pitfalls. Through a series of use cases\, attendees will learn about expert-curated knowledge from the Wellcome Sanger Institute and QIAGEN\, and how to use these resources to better predict cancer-driving effects of mutations\, identify available drugs that target specific variants\, and accelerate indication expansion and repurposing of existing cancer therapies. \nLearning objectives: \n1. Examine use-cases of how to leverage expert-curated databases across multiple phases of cancer drug development. \n2. Discover key applications of these databases\, including determining the function\, frequency\, and actionability of specific mutations. \n3. Discuss potential pitfalls and clinical consequences\, and how to avoid them early with data-driven drug target and biomarker qualification.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-biopharmaceutical-companies-can-leverage-expert-curated-knowledge-from-wellcome-sanger-institute-and-qiagen-to-accelerate-cancer-drug-discovery-and-development/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1366_2_QDI_QCI_HSMDvsCOSMIC_Biopharmam.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240220T130000
DTEND;TZID=America/New_York:20240220T143000
DTSTAMP:20260404T211905
CREATED:20240111T165213Z
LAST-MODIFIED:20241024T183004Z
UID:10000722-1708434000-1708439400@staging.digitalinsights.supremeclients.com
SUMMARY:Mining curated knowledge graphs and validating with experimental datasets to accelerate your drug target discovery
DESCRIPTION:In an era of near-limitless public experimental data but little standardization\, meaningful insights are lost to noise. Large collections of quality experimental data are essential for big-picture discoveries that stand up to scrutiny. \nIn this webinar\, you will learn how to feed your drug discovery programs by integrating connections mined from QIAGEN Biomedical Knowledge Base with deeply curated disease datasets from QIAGEN OmicSoft Lands. \nCombining unified 'omics datasets with contextual relationship evidence from our knowledge graph\, we will address complex questions such as:   \n\n Which genes aren't expressed in normal tissue\, yet are expressed in diseases of interest\, based on experimental evidence?\n Which of these proteins are cell surface proteins\, with evidence for extracellular localization?\n How are these proteins related directly or indirectly to disease pathways\, and can these be connected to known drug targets?\n Can we identify correlated biomarkers\, mutation targets\, clinical factors or other means of cohort selection?
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/mining-curated-knowledge-graphs-and-validating-with-experimental-datasets-to-accelerate-your-drug-target-discovery/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240215T130000
DTEND;TZID=America/New_York:20240215T143000
DTSTAMP:20260404T211905
CREATED:20240215T173235Z
LAST-MODIFIED:20241024T183022Z
UID:10000729-1708002000-1708007400@staging.digitalinsights.supremeclients.com
SUMMARY:ATCC cell line data utilization for cell line selection\, validation and other applications
DESCRIPTION:Cancer cell line models have been a cornerstone of cancer research for decades. Profiling cancer cell lines can be a powerful tool to identify gene alterations or cancer-related pathways and aid in discovering putative drug targets. In this webinar\, we'll use QIAGEN OmicSoft Lands and QIAGEN Ingenuity Pathway Analysis (IPA) to help you select cell lines and translate insights from your cell line experiments for drug target discovery. \nDuring this 90-minute discussion\, we'll explore how you can use these software tools to:\n• Select appropriate cancer cell lines for a variety of applications such as drug discovery\, precision disease modeling\, understanding gene function in cancer\, immune-oncology research and more\n• Examine various 'omics data for genes of interest for expression\, mutation\, hotspots and gene dependency data\n• Generate networks for hypotheses and test them in silico to improve the translation of insights derived from cell line models to the drug target identification\n• Integrate analyses of public 'omics data and drug response phenotypes using cell line model systems by exploring data from the Library of Integrated Network-Based Cellular Signatures (LINCS)\n• Prioritize drug targets and profile phenotypic/downstream effects of drug action by overlaying public data on user-generated networks \nOur system uses millions of curated literature findings from QIAGEN Knowledge Base and the OmicSoft digital warehouse. This discussion is intended for both those familiar with QIAGEN IPA and newcomers interested in learning more.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/atcc-cell-line-data-utilization-for-cell-line-selection-validation-and-other-applications/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1276_1_QDI_QDI_ATCC_Generic.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240215T080000
DTEND;TZID=UTC:20240215T170000
DTSTAMP:20260404T211905
CREATED:20260404T211905Z
LAST-MODIFIED:20241024T183022Z
UID:10000730-1707984000-1708016400@staging.digitalinsights.supremeclients.com
SUMMARY:Single Cell RNA-Seq\, Cell Hashing\, and Spatial Transcriptomics
DESCRIPTION:In this training\, you will learn how to analyze and interpret your own single-cell RNA-seq data using QIAGEN CLC Genomics Workbench starting with either FASTQ or matrix files. \nUsing CLC Genomics Workbench\, you will learn how to perform secondary analysis on your single-cell RNA-seq data. Specifically\, you will learn how to:\n• Import your raw FASTQ or processed cell-matrix files.\n• Use pre-configured but customizable pipelines/workflows for single-cell RNA-seq data.\n• Generate high-resolution visuals and other files from your analysis for publications and biopharmaceutical discoveries.\no Dimension reduction (UMAP\, t-SNE) plots\no Differential expression table for clusters\, cell types\, or a combination of both\no Heat map\no Dot plots\no Violin plots\n• Learn how to use “Create Cell Annotations from Hashtags” for cell hashing (i.e.\, CITE-seq).\n• Dive into spatial transcriptomic analysis\, the latest feature in the single cell RNA-seq module.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/single-cell-rna-seq-cell-hashing-and-spatial-transcriptomics/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240214T160000
DTEND;TZID=Europe/Paris:20240214T170000
DTSTAMP:20260404T211905
CREATED:20240111T164643Z
LAST-MODIFIED:20241024T183003Z
UID:10000721-1707926400-1707930000@staging.digitalinsights.supremeclients.com
SUMMARY:Introduction to Analysis Match in IPA - Compare your gene and protein expression data to over 100.000 published experimental data
DESCRIPTION:With all the expression datasets that are available to the public\, wouldn’t it be great to compare them to your own expression data\, so you could get a better understanding of the underlying biology of your data? \nWith QIAGEN IPA Analysis Match\, you can compare your expression data with well over 100\,000 publicly available datasets that have been processed and analyzed in IPA\, as well as all the IPA analyses that you have performed to date. \nIn this webinar\, we will cover how Analysis Match works and demonstrate this feature with a live demonstration. Feel free to follow along with your analysis and ask questions along the way!
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/introduction-to-analysis-match-in-ipa-compare-your-gene-and-protein-expression-data-to-over-100-000-published-experimental-data-2-2/
LOCATION:Virtual - EMEA - CET
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1233_1_QDI_QDI_IPA_AOP_16x9_63871_Large-1200px-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240214T100000
DTEND;TZID=America/New_York:20240214T110000
DTSTAMP:20260404T211905
CREATED:20240111T164231Z
LAST-MODIFIED:20241024T183002Z
UID:10000720-1707904800-1707908400@staging.digitalinsights.supremeclients.com
SUMMARY:Introduction to Analysis Match in IPA - Compare your gene and protein expression data to over 100.000 published experimental data
DESCRIPTION:With all the expression datasets that are available to the public\, wouldn’t it be great to compare them to your own expression data\, so you could get a better understanding of the underlying biology of your data? \nWith QIAGEN IPA Analysis Match\, you can compare your expression data with well over 100\,000 publicly available datasets that have been processed and analyzed in IPA\, as well as all the IPA analyses that you have performed to date. \nIn this webinar\, we will cover how Analysis Match works and demonstrate this feature with a live demonstration. Feel free to follow along with your analysis and ask questions along the way!
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/introduction-to-analysis-match-in-ipa-compare-your-gene-and-protein-expression-data-to-over-100-000-published-experimental-data-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1233_1_QDI_QDI_IPA_AOP_16x9_63871_Large-1200px-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240213T130000
DTEND;TZID=America/New_York:20240213T143000
DTSTAMP:20260404T211905
CREATED:20240111T143538Z
LAST-MODIFIED:20241024T183001Z
UID:10000719-1707829200-1707834600@staging.digitalinsights.supremeclients.com
SUMMARY:Long reads analysis using CLC Genomics workbench (with new features - 2024)
DESCRIPTION:This webinar will introduce users to the long read support plugin for Oxford Nanopore and PacBio sequencing reads in QIAGEN CLC Genomics Workbench. \nParticipants will learn the following: \n• Download and install needed plugins.\n• Import data required for the analysis.\n• Long read de novo assembly.\n• Map reads to a reference and visualize an assembly.\n• Use BLAST to investigate the contigs.\n• Additional long read tools: polish with short reads\, structural variant calling.\n• Genome finishing tools: analyze and assemble contigs\n• Analytical tools: RNA-seq analysis for long reads\, classify long read amplicons for metagenomics.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/long-reads-analysis-using-clc-genomics-workbench-with-new-features-2024/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1108_8_QDI_CLC_Challenger_Or54963_16x9_56810_Large-1200px-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240208T130000
DTEND;TZID=America/New_York:20240208T150000
DTSTAMP:20260404T211905
CREATED:20240111T141714Z
LAST-MODIFIED:20241024T183000Z
UID:10000718-1707397200-1707404400@staging.digitalinsights.supremeclients.com
SUMMARY:New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:Join us for a 120-minute training session for new users of QIAGEN IPA. \nIn this training\, you’ll learn how to:\n• Upload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more) and perform interactive core/pathway analysis in IPA\n• Understand the different result types produced (pathways\, key regulators\, impact on biological functions/diseases and more)\n• Compare different experimental conditions (treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\n• Generate a network even without a dataset or experimental design for hypothesis generation
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-user-training-large-dataset-analysis-and-knowledge-base-queries-using-qiagen-ingenuity-pathway-analysis-ipa-8/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9785_QDI_IPA_GI545875183_16x9_54188_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240130T130000
DTEND;TZID=America/New_York:20240130T140000
DTSTAMP:20260404T211905
CREATED:20240116T144109Z
LAST-MODIFIED:20241024T183016Z
UID:10000725-1706619600-1706623200@staging.digitalinsights.supremeclients.com
SUMMARY:What’s new in QIAGEN CLC Genomics Workbench version 24 - NA/LATAM
DESCRIPTION:QIAGEN CLC Genomics Workbench version 24 is here with exciting updates we'd like to share with you. These include: \n\nOur QIAGEN CLC LightSpeed Module which now provides ultrafast somatic workflows\nSpatial Transcriptomics and ParseBio support in QIAGEN CLC Single Cell Analysis Module\nAmplicon classification for ONT reads in QIAGEN CLC Microbial Genomics Module\nNew Structural variant detection for long read and De novo assembly of PacBio HiFi reads\nImporter for Element\, PacBio Onso\, Ultima reads\, Singular\nCRAM format importer / exporter\nFancy new interactive RNAseq Volcano plot for RNAseq\nAnd many more new and improved workflow and reporting capabilities\n\nJoin this webinar to: \n\nLearn how to take advantage of the latest improvements\nGet an overview of the many tools available to you\nMake sure to join this webinar to elevate your understanding of current trends in bioinformatics\n\nCan't make it at this time? Don't worry. Register now and we will send you the on-demand recording so you can catch up on what you missed.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/whats-new-in-qiagen-clc-genomics-workbench-version-24-na-latam/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/webinar_speaker_QDI_CLC_GEN_16x9_2024.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240130T100000
DTEND;TZID=Europe/Paris:20240130T110000
DTSTAMP:20260404T211905
CREATED:20240116T143917Z
LAST-MODIFIED:20241024T183014Z
UID:10000724-1706608800-1706612400@staging.digitalinsights.supremeclients.com
SUMMARY:What’s new in QIAGEN CLC Genomics Workbench version 24 - EMEA/APAC
DESCRIPTION:QIAGEN CLC Genomics Workbench version 24 is here with exciting updates we'd like to share with you. These include: \n\nOur QIAGEN CLC LightSpeed Module which now provides ultrafast somatic workflows\nSpatial Transcriptomics and ParseBio support in QIAGEN CLC Single Cell Analysis Module\nAmplicon classification for ONT reads in QIAGEN CLC Microbial Genomics Module\nNew Structural variant detection for long read and De novo assembly of PacBio HiFi reads\nImporter for Element\, PacBio Onso\, Ultima reads\, Singular\nCRAM format importer / exporter\nFancy new interactive RNAseq Volcano plot for RNAseq\nAnd many more new and improved workflow and reporting capabilities\n\nJoin this webinar to: \n\nLearn how to take advantage of the latest improvements\nGet an overview of the many tools available to you\nMake sure to join this webinar to elevate your understanding of current trends in bioinformatics\n\nCan't make it at this time? Don't worry. Register now and we will send you the on-demand recording so you can catch up on what you missed.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/whats-new-in-qiagen-clc-genomics-workbench-version-24-emea-apac/
LOCATION:Virtual - EMEA - CET
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/webinar_speaker_QDI_CLC_GEN_16x9_2024.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20240124T160000
DTEND;TZID=Europe/Paris:20240124T170000
DTSTAMP:20260404T211905
CREATED:20240110T150321Z
LAST-MODIFIED:20241024T182959Z
UID:10000717-1706112000-1706115600@staging.digitalinsights.supremeclients.com
SUMMARY:Exploring RNA-seq data using the CLC Genomics Workbench: Expression Analysis and upload to Ingenuity Pathway Analysis (IPA) - EMEA/APAC
DESCRIPTION:In this webinar\, we will present how to analyze RNA-seq data starting from raw sequencing reads. We will touch upon expression analysis\, statistical comparison\, visualization and functional enrichment of RNA-seq data using an actual dataset and a live demo. \nDuring this webinar\, we will cover: \n\nMapping of reads to the reference and abundance estimation\nPrincipal component analysis (PCA) of RNA-seq data\nDifferential expression analysis\nVisualization of results using volcano plots\, heatmaps and Venn diagrams\nCreating RNA-seq expression table and adding GO annotations\nGene set enrichment analysis using hypergeometric test\nReady-to-use Workflows for expression analysis\nUpload to Ingenuity Pathway Analysis (IPA)\n\nBring any questions you may have\, and we will answer them during the webinar.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/exploring-rna-seq-data-using-the-clc-genomics-workbench-expression-analysis-and-upload-to-ingenuity-pathway-analysis-ipa-2/
LOCATION:Virtual - EMEA - CET
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1040_8_QDI_CLC_GWBv21_Gi470306612_16x9_Large-1200px_53596-768x432-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240124T100000
DTEND;TZID=America/New_York:20240124T110000
DTSTAMP:20260404T211905
CREATED:20240110T122143Z
LAST-MODIFIED:20241024T182959Z
UID:10000716-1706090400-1706094000@staging.digitalinsights.supremeclients.com
SUMMARY:Exploring RNA-seq data using the CLC Genomics Workbench: Expression Analysis and upload to Ingenuity Pathway Analysis (IPA) - NA/LATAM
DESCRIPTION:In this webinar\, we will present how to analyze RNA-seq data starting from raw sequencing reads. We will touch upon expression analysis\, statistical comparison\, visualization and functional enrichment of RNA-seq data using an actual dataset and a live demo. \nDuring this webinar\, we will cover: \n\nMapping of reads to the reference and abundance estimation\nPrincipal component analysis (PCA) of RNA-seq data\nDifferential expression analysis\nVisualization of results using volcano plots\, heatmaps and Venn diagrams\nCreating RNA-seq expression table and adding GO annotations\nGene set enrichment analysis using hypergeometric test\nReady-to-use Workflows for expression analysis\nUpload to Ingenuity Pathway Analysis (IPA)\n\nBring any questions you may have\, and we will answer them during the webinar.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/exploring-rna-seq-data-using-the-clc-genomics-workbench-expression-analysis-and-upload-to-ingenuity-pathway-analysis-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1040_8_QDI_CLC_GWBv21_Gi470306612_16x9_Large-1200px_53596-768x432-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240118T130000
DTEND;TZID=America/New_York:20240118T143000
DTSTAMP:20260404T211905
CREATED:20231213T142224Z
LAST-MODIFIED:20241024T182958Z
UID:10000715-1705582800-1705588200@staging.digitalinsights.supremeclients.com
SUMMARY:IPA deeper dive: Making most out of user’s core/expression analysis and new features
DESCRIPTION:Many of you who use QIAGEN Ingenuity Pathway Analysis (IPA) have requested a deeper dive into the IPA core analysis (also known as expression analysis)\, which is - performed on RNA-seq\, scRNA-seq\, proteomics and many other types of ‘omics data). You’ve specifically requested to cover topics like causal networks\, regulator effects\, etc.\, in more detail. That’s why we’ve designed this training to focus on these topics and more:\n· What are the different result types of results produced by an IPA core analysis?\n· What are the differences between causal network vs. mechanistic network vs. regulator effects?\n· How do you predict molecular activity in IPA? What is a Z-score? · What is the new bubble plot feature?\n· How can I edit\, expand and modify the network the way I want it? For example\, add a disease or gene(s) of interest\, remove certain connections\, etc?\n• If you haven’t done a core/expression analysis in IPA before\, we recommend you review the below slides before (or after) this training. It’s not a requirement for following this training but it will help.\no https://qiagen.showpad.com/share/SQjinvdxIs1iGhL8H3eOd\n Slide#4 = how to download the example dataset\n Slide#20 -25 = review recommended dataset formats\n Slide#53 onwards = step-by-step how to upload the dataset and perform analysis\n• If you have an IPA license but don't know where to download the IPA app.\no Install IPA: https://qiagen.showpad.com/share/A0mV7EWcejBtXPJUesbXd\no IPA beginner training recording:\n https://qiagen.showpad.com/share/t2cGMdF3NjVucBA0b9tIT
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/ipa-deeper-dive-making-most-out-of-users-core-expression-analysis-and-new-features/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1036_9_QDI_IPAviral_Gi683847570_16x9_Large-1200px_53562.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240116T130000
DTEND;TZID=America/New_York:20240116T143000
DTSTAMP:20260404T211905
CREATED:20231213T141545Z
LAST-MODIFIED:20241024T182955Z
UID:10000714-1705410000-1705415400@staging.digitalinsights.supremeclients.com
SUMMARY:Sanger sequencing\, alignment\, cloning\, primer design and more using QIAGEN CLC Main and Genomics Workbench software
DESCRIPTION:If you're a QIAGEN CLC Main and/or Genomics Workbench user\, or interested in learning about the below analytics\, you won't want to miss this training: \n• Alignment and tree construction\n• Sanger sequencing analysis\n• Cloning and primer design\n• Other molecular biology tools
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/sanger-sequencing-alignment-cloning-primer-design-and-more-using-qiagen-clc-main-and-genomics-workbench-software/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/bioX_main.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240116T110000
DTEND;TZID=America/New_York:20240116T120000
DTSTAMP:20260404T211905
CREATED:20231211T125811Z
LAST-MODIFIED:20241024T182954Z
UID:10000711-1705402800-1705406400@staging.digitalinsights.supremeclients.com
SUMMARY:Case studies: Real world examples of how labs can use HGMD Professional to mitigate errors in variant interpretation
DESCRIPTION:The clinical interpretation of genetic testing results remains one of the most significant hurdles in effectively applying genomics in modern medicine. Errors in variant interpretation\, whether false positives or false negatives\, can result in inappropriate medical interventions or missed opportunities for treatment. To mitigate the risks associated with variant misinterpretation\, the professional genetics community has established guidelines for variant annotation. However\, putting these guidelines into practice is difficult and time-consuming\, requiring a meticulous process of gathering data and compiling evidence for each identified genetic variant and drawing information from various sources to assess its clinical significance. Therefore\, the accuracy of variant annotation significantly relies on reputable and regularly updated reference databases that contain information about well-documented genetic variants and their clinical implications.\n\nJoin Dr. Ana Krivokuca\, The Head of the Department of Genetic Counselling at the Institute of Oncology and Radiology Serbia\, as she presents a case study webinar on how to use the Human Gene Mutation Database (HGMD) Professional\, a comprehensive\, diverse\, meticulously annotated and regularly updated resource for finding disease-causing mutations\, for multiple clinical genetic testing applications.\n\nIn this webinar\, attendees will:\n\nExamine three neurological disorder case studies of how to use HGMD Professional to link phenotypes to causative variants\, identify and interpret clinically relevant variants\, discover ethnically relevant variants\, and develop gene panels.\nLearn how HGMD Professional is maintained by a team of expert curators and updated every three months.\nHear a real-life story of how HGMD Professional can help prevent misdiagnoses with an example of variant misclassification causing inappropriate and devastating medical intervention.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/case-studies-real-world-examples-of-how-labs-can-use-hgmd-professional-to-mitigate-errors-in-variant-interpretation/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/HGMDPageThumbnail.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240111T130000
DTEND;TZID=America/New_York:20240111T143000
DTSTAMP:20260404T211905
CREATED:20231213T141124Z
LAST-MODIFIED:20241024T182955Z
UID:10000713-1704978000-1704983400@staging.digitalinsights.supremeclients.com
SUMMARY:New feature: RNA-seq Analysis Portal in QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:RNA-seq Analysis Portal\, a cloud-based platform you can access from a web browser\, helps you analyze your RNA-seq expression data. Its predefined analysis pipelines let you calculate expression levels and identify differential expression and significant pathways\, regulators\, diseases and functions in just a few steps. \nThe graphical views and interactive plots enable seamless exploration and refinement of your RNA-seq analysis results. RNA-seq Analysis Portal is available to those with a MyQIAGEN or QIAGEN IPA account. MyQIAGEN users can pass results to QIAGEN GeneGlobe Design and Analysis Hub to explore and plan next steps\, such as qPCR or dPCR-based follow-up experiments for your filtered target genes. \nIf you're a QIAGEN IPA user\, you can use RNA-seq Analysis Portal for secondary analysis of raw sequencing data and do preliminary analysis before uploading your resulting dataset to QIAGEN IPA. You can also use it to process and analyze public RNA-seq data. \nIn this webinar\, you'll learn how to:\n* Upload your own FASTQ files or search for public RNA-seq data\n* Perform alignment\, QC and generate counts\n* Generate differential expression\, heatmap\, volcano plot and other results\n* Export results to QIAGEN IPA
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-feature-rna-seq-analysis-portal-in-qiagen-ingenuity-pathway-analysis-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1112_2_Genomics_RAP_Gi899339130.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240104T130000
DTEND;TZID=America/New_York:20240104T150000
DTSTAMP:20260404T211905
CREATED:20231213T140628Z
LAST-MODIFIED:20241024T182955Z
UID:10000712-1704373200-1704380400@staging.digitalinsights.supremeclients.com
SUMMARY:New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:Join us for a 120-minute training session for new users of QIAGEN IPA. \nIn this training\, you’ll learn how to:\n• Upload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more) and perform interactive core/pathway analysis in IPA\n• Understand the different result types produced (pathways\, key regulators\, impact on biological functions/diseases and more)\n• Compare different experimental conditions (treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\n• Generate a network even without a dataset or experimental design for hypothesis generation
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-user-training-large-dataset-analysis-and-knowledge-base-queries-using-qiagen-ingenuity-pathway-analysis-ipa-7/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9785_QDI_IPA_GI545875183_16x9_54188_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231214T130000
DTEND;TZID=America/New_York:20231214T150000
DTSTAMP:20260404T211905
CREATED:20231108T123505Z
LAST-MODIFIED:20241024T182952Z
UID:10000705-1702558800-1702566000@staging.digitalinsights.supremeclients.com
SUMMARY:RNA-seq data analysis and interpretation with sankey plot update
DESCRIPTION:During this 120-minute training\, we’ll teach you how to easily analyze and interpret RNA-seq data using QIAGEN CLC Genomics Workbench and QIAGEN Ingenuity Pathway Analysis (IPA) software.  For RNA-seq data\, you will learn how to: • Import FASTQ files\, cell-matrix files and metadata and how to download references • Map reads to a reference genome and generate gene and transcript counts and QC reports displaying % mapped reads\, knee plots\, etc. • Generate visualizations of results\, such as heatmaps\, differential expression tables\, PCA/PCOA plots\, Venn diagrams\, sankey plot and others • Easily customize RNA-seq workflows • Export publication-quality graphics\, tables and reports • Send differential expression tables to QIAGEN Ingenuity Pathway Analysis directly from QIAGEN CLC Genomics Workbench to analyze and interpret relevant pathways  Here you can explore the types of analyses and visualizations you'll learn to generate (slides from previous training): https://qiagen.showpad.com/share/qiZLmCUS32GZNM1B4llMf 
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/rna-seq-data-analysis-and-interpretation-with-sankey-plot-update/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1140_5_QDI_CLC_V22_16x9_Large-1200px_58739.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231213T110000
DTEND;TZID=America/New_York:20231213T120000
DTSTAMP:20260404T211905
CREATED:20231201T164654Z
LAST-MODIFIED:20241024T182954Z
UID:10000710-1702465200-1702468800@staging.digitalinsights.supremeclients.com
SUMMARY:One tool to help biopharma accelerate cancer drug discovery and repurposing: A translational research use-case and discussion
DESCRIPTION:The development of new cancer drugs is challenging\, costly\, and time-consuming. As translational research on cancer diagnostics and genomic profiling rapidly evolves\, the ability to confidently and efficiently identify specific oncogenes and tumor suppressors involved in oncogenesis is becoming increasingly difficult. \nThis brief half-hour webinar is intended for biopharmaceutical and biotechnology professionals who need more efficient ways of discovering\, developing\, and repurposing drugs for oncology applications. During the session\, attendees will explore a demonstration and a use-case presented by Dr. Kyle Nilson\, providing insights into the Human Somatic Mutation Database (HSMD)—a new somatic database developed by QIAGEN that contains extensive genomic content relevant to solid tumors and hematological malignancies. \nHSMD is an exceptional resource for biopharmaceutical and biotechnology companies\, facilitating the confident evaluation of cancer-related genetic variations by granting access to real-world data. Powered by QIAGEN’s extensive artificial intelligence (AI)-enabled Knowledge Base\, robust curation team composed of over 100 expert curators (MD and PhD level)\, and data from QIAGEN’s professional variant interpretation service (previously N-of-One)\, HSMD encompasses a vast repository of over 4.7 million meticulously curated genetic alteration findings and variant data over 500\,000 somatic patient cases. Attendees will explore how HSMD enables biopharmaceutical and biotechnology companies to gain deeper insights into the molecular cancer profiles\, identify therapeutic options\, and develop strategies for finding new therapies for a particular cancer type or even for a particular patient. \nAttendees will: \n\nLearn what content sources power HSMD\nUnderstand how to use and apply HSMD for multiple applications\, including translational research and pharmaceutical development\nExamine a use case of how to use HSMD to accelerate research\, development and repurposing in cancer drug development programs\nReceive a complimentary 5-day trial of HSMD
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/one-tool-to-help-biopharma-accelerate-cancer-drug-discovery-and-repurposing-a-translational-research-use-case-and-discussion/
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1144_5_QDI_QCI_HSMD_GI646221430_16x9_59476_Large-1200px-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231213T100000
DTEND;TZID=America/New_York:20231213T110000
DTSTAMP:20260404T211905
CREATED:20231108T123149Z
LAST-MODIFIED:20241024T182953Z
UID:10000706-1702461600-1702465200@staging.digitalinsights.supremeclients.com
SUMMARY:How to perform DNA-seq and resequencing data analyses using QIAGEN CLC Genomics Workbench
DESCRIPTION:In this webinar\, we’ll introduce algorithms required to perform data analysis for resequencing next-generation sequencing data. Together\, we’ll explore:  • Read mapper • Variant callers • Annotations and filters • Genome Browser  Bring any questions you may have\, and we will answer them during the webinar. 
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-to-perform-dna-seq-data-analysis-with-clc-genomics-workbench-resequencing/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1109_4_QDI_CLC_Challenger_Or55819-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231212T130000
DTEND;TZID=America/New_York:20231212T140000
DTSTAMP:20260404T211905
CREATED:20231108T122647Z
LAST-MODIFIED:20241024T182950Z
UID:10000704-1702386000-1702389600@staging.digitalinsights.supremeclients.com
SUMMARY:Target exploration and cell line selection for drug discovery
DESCRIPTION:Cancer cell line models have been a cornerstone of cancer research for decades. Cancer cell lines profiling can be a powerful tool for the identification of genes’ alterations or pathways cancer-related and for the discovery of putative drug targets. This webinar will focus using Qiagen OmicSoft Lands and Ingenuity Pathway Analysis as guides for the selection of cell lines and translation of insights gained from cell lines for drug target discovery. \nThis 90-minute event will show how our platform enables scientists:\n• Select appropriate cancer cell lines for a variety of applications such as drug discovery\, precision disease modeling\, understanding gene function in cancer\, immune-oncology research.\n• Examine various ‘omics data for genes of interest for expression\, mutation\, hotspots\, and gene dependency data.\n• Generate networks for hypotheses and test the in-silico to improve translation of insights derived from cell line models to the drug target identification.\n• Integrated analyses of public 'omics data and drug response phenotypes using cell line model systems by exploring data from the Library of Integrated Network-Based Cellular Signatures (LINCS).\n• How to prioritize drug targets and profile phenotypic/downstream effects of drug action by overlaying public data on user generated networks. \nOur system uses millions of curated literature findings in the QIAGEN/ IPA knowledge base and the OmicSoft digital warehouse. The presentation is intended for both those familiar with Ingenuity Pathway and newcomers interested in learning more.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/target-exploration-and-cell-line-selection-for-drug-discovery-2/
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1063_9_OmicSoft-Single-Cell-Lands_028687_16x9.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231207T130000
DTEND;TZID=America/New_York:20231207T140000
DTSTAMP:20260404T211905
CREATED:20231108T121640Z
LAST-MODIFIED:20241024T182950Z
UID:10000703-1701954000-1701957600@staging.digitalinsights.supremeclients.com
SUMMARY:Mining curated knowledge graphs and validating with experimental datasets to accelerate your drug target discovery
DESCRIPTION:In an era of near-limitless public experimental data but little standardization\, meaningful insights are lost to noise. Large collections of quality experimental data are essential for big-picture discoveries that stand up to scrutiny.  In this webinar\, you will learn how to feed your drug discovery programs by integrating connections mined from QIAGEN Biomedical Knowledge Base with deeply-curated disease datasets from QIAGEN OmicSoft Lands.  Combining unified 'omics datasets with contextual relationship evidence from our knowledge graph\, we will address complex questions such as: • Which genes aren't expressed in normal tissue\, yet are expressed in diseases of interest\, based on experimental evidence? • Which of these proteins are cell surface proteins\, with evidence for extracellular localization? • How are these proteins related directly or indirectly to disease pathways\, and can these be connected to known drug targets? • Can we identify correlated biomarkers\, mutation targets\, clinical factors or other means of cohort selection?
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/mine-curated-knowledge-graphs-and-validate-with-experimental-datasets-for-drug-target-discovery-2-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1052_1_QDI_OmicSoft_16x9.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231207T110000
DTEND;TZID=America/New_York:20231207T120000
DTSTAMP:20260404T211905
CREATED:20231115T130508Z
LAST-MODIFIED:20241024T182953Z
UID:10000708-1701946800-1701950400@staging.digitalinsights.supremeclients.com
SUMMARY:Translating COSMIC's gold standard data into actionable insights
DESCRIPTION:As the vast landscape of genetic oncology continues to expand\, the ability to understand and utilize the full potential of this rich data becomes increasingly challenging. As a result\, researchers\, scientists\, and clinicians need an accessible\, streamlined and standardized way of keeping track of this potentially crucial\, ever-growing body of actionable knowledge. Over the course of 20 years\, COSMIC\, the Catalogue Of Somatic Mutations In Cancer\, has expertly curated the world’s largest\, most comprehensive database for somatic mutation information relating to human cancer. Today\, COSMIC is used worldwide by revered research and clinical institutes\, biotech and pharmaceutical companies\, and more.\n\nIn this webinar\, Leonie Hodges\, Scientific Communications Officer for COSMIC\, will delve into the wide range of datasets that COSMIC offers\, detailing the content\, how to obtain actionable insights from the genomic data\, and how to potentially use this data for real-world applications. Following the talk\, there will be a live Q&A with Jennifer Wilding\, Scientist Curator at COSMIC and Alex Holmes\, Senior Database Curator at COSMIC.\n\nBy attending this webinar\, you will learn how to:\n\nExplore the wide range of datasets that COSMIC offers\, including the Cancer Mutation Census and Mutational Signatures;\nGain insights from COSMIC’s gold standard genomic data by taking either a disease or gene centric view of your research;\nIdentify potential applications of COSMIC data and how it enables users from a plethora of disciplines to experiment and innovate with confidence.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/translating-cosmics-gold-standard-data-into-actionable-insights/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1229_4_QDI_QCI_COSMIC_Actionabilityv5.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20231206T140000
DTEND;TZID=Europe/Paris:20231206T150000
DTSTAMP:20260404T211905
CREATED:20231108T121513Z
LAST-MODIFIED:20241024T182949Z
UID:10000702-1701871200-1701874800@staging.digitalinsights.supremeclients.com
SUMMARY:Mining curated knowledge graphs and validating with experimental datasets to accelerate your drug target discovery
DESCRIPTION:In an era of near-limitless public experimental data but little standardization\, meaningful insights are lost to noise. Large collections of quality experimental data are essential for big-picture discoveries that stand up to scrutiny.  In this webinar\, you will learn how to feed your drug discovery programs by integrating connections mined from QIAGEN Biomedical Knowledge Base with deeply-curated disease datasets from QIAGEN OmicSoft Lands.  Combining unified 'omics datasets with contextual relationship evidence from our knowledge graph\, we will address complex questions such as: • Which genes aren't expressed in normal tissue\, yet are expressed in diseases of interest\, based on experimental evidence? • Which of these proteins are cell surface proteins\, with evidence for extracellular localization? • How are these proteins related directly or indirectly to disease pathways\, and can these be connected to known drug targets? • Can we identify correlated biomarkers\, mutation targets\, clinical factors or other means of cohort selection?
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/mine-curated-knowledge-graphs-and-validate-with-experimental-datasets-for-drug-target-discovery-3/
LOCATION:Virtual - EMEA - CET
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1052_1_QDI_OmicSoft_16x9.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231205T130000
DTEND;TZID=America/New_York:20231205T150000
DTSTAMP:20260404T211905
CREATED:20231106T171550Z
LAST-MODIFIED:20241024T182949Z
UID:10000701-1701781200-1701788400@staging.digitalinsights.supremeclients.com
SUMMARY:New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:\,\nIn this training\, you’ll learn how to:\n• Upload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more) and perform interactive core/pathway analysis in IPA\n• Understand the different result types produced (pathways\, key regulators\, impact on biological functions/diseases and more)\n• Compare different experimental conditions (treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\n• Generate a network even without a dataset or experimental design for hypothesis generation \nFor those with IPA license\,\nTo install IPA before or after this training\, please use below installer.\nhttps://qiagen.showpad.com/share/CBv30blCPKFDUYHRWtAvI
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-user-training-large-dataset-analysis-and-knowledge-base-queries-using-qiagen-ingenuity-pathway-analysis-ipa-6/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/png:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/guy-with-new-IPA-picture.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231205T110000
DTEND;TZID=America/New_York:20231205T120000
DTSTAMP:20260404T211905
CREATED:20231120T172709Z
LAST-MODIFIED:20241024T182953Z
UID:10000709-1701774000-1701777600@staging.digitalinsights.supremeclients.com
SUMMARY:Comprehensive Molecular Tumor Analysis (CMTA) integrating RNAseq and tumor immune microenvironment (TME) for targeted therapy
DESCRIPTION:Precision oncology approaches have made great strides harnessing individual tumor mutation profiles to guide targeted therapy choices. However\, deeper molecular insights are needed to improve personalized treatment decisions that are tailored to specific molecular characteristics of a tumor. Integrating gene expression analysis in personalized oncology provides an additional level of insight that cannot be provided by genomic data alone. These analyses include evaluating expressed mutations and drug targets\, novel gene fusions\, clinically relevant signatures\, and the tumor immune microenvironment (TME). \nComprehensive Molecular Tumor Analysis (CMTA) is a NGS-based innovative tumor diagnostic test developed by Alacris Theranostics. The test integrates whole exome and transcriptomic sequencing (WES and RNAseq) and is deployed as an end-to-end accredited diagnostic platform from tumor sample uptake (FFPE or frozen) to personalized clinical interpretation report. Designed to serve all cancer patients\, CMTA is a tumor-agnostic test that displays a unique molecular view into each individual sample\, which is particularly well-suited to refractory cancers with complex patterns or tumors of unknown origin. \nIn this webinar\, Alacris Theranostics will discuss the benefits of comprehensive tumor profiling in clinical settings and present the strategy implemented in their bioinformatics pipeline to identify cancer-relevant somatic events. In addition\, the diagnostic company will share how they use QIAGEN Clinical Insight (QCI) Interpret to annotate variants and identify potential therapeutic entry-points.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/comprehensive-molecular-tumor-analysis-cmta-integrating-rnaseq-and-tumor-immune-microenvironment-tme-for-targeted-therapy/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1305_6_QDI_QCI_Gi1388387853-3.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231129T100000
DTEND;TZID=America/New_York:20231129T110000
DTSTAMP:20260404T211905
CREATED:20231106T170915Z
LAST-MODIFIED:20241024T182948Z
UID:10000700-1701252000-1701255600@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN CLC Genomics Workbench for your miRNA data analyses
DESCRIPTION:Join us for our webinar\, where we'll focus on miRNA data analysis using QIAGEN CLC Genomics Workbench and Biomedical Genomics Analysis plugin. Together\, we'll explore how you can: • Import reads and metadata • Download miRBase database • Quantify miRNA expression • Perform differential expression analysis • Visualize your results • Create and use a custom database  Bring any questions you may have\, and we will answer them during the webinar. 
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/mirna-data-analysis-with-qiagen-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1140_4_QDI_CLC_V22_16x9_Large-1200px_58733.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231116T130000
DTEND;TZID=America/New_York:20231116T143000
DTSTAMP:20260404T211905
CREATED:20231012T165109Z
LAST-MODIFIED:20241024T182944Z
UID:10000694-1700139600-1700145000@staging.digitalinsights.supremeclients.com
SUMMARY:Making discoveries from public data (GEO\, SRA and more) using QIAGEN Ingenuity Pathway Analysis
DESCRIPTION:You requested it\, and we’re here to deliver. We’re excited to offer you comprehensive training on how to effectively use sample-level public data and metadata from sources like GEO\, SRA\, TCGA\, GTEx\, Blueprint\, CCLE and other sources through QIAGEN Ingenuity Pathway Analysis (IPA) and the IPA Analysis Match Explorer feature. Your trainer will walk you through use cases in related to biomarker discovery\, drug target investigation\, studying survival in custom patient cohorts\, multi-gene correlation and more. Note: The word “condition” below refers to different diseases\, disease subtypes\, treatments\, cell types\, cell lines and more.  \nIn this training\, we’ll cover topics such as: • How is a gene of interest expressed across different conditions? • Is there a correlation in expression for two genes or biomarkers of user interest for a given condition? • For a given condition of interest\, can we derive a list of genes (for example\, genes specific to a disease\, treatment or cell type)? • Can we generate custom cohorts of patients (for example\, TP53 wt vs mutant or PDCD1 high vs low expression) and then generate survival curves representing those cohorts? Can we generate p-value to see if there is a significant difference? • Recent update: Can we detect the expression of a gene in different cell types from single-cell data? 
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/making-discoveries-from-public-data-geo-sra-and-more-using-qiagen-ingenuity-pathway-analysis/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1052_1_QDI_OmicSoft_16x9.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20231116T130000
DTEND;TZID=America/Halifax:20231116T140000
DTSTAMP:20260404T211905
CREATED:20231026T115707Z
LAST-MODIFIED:20241024T182947Z
UID:10000697-1700139600-1700143200@staging.digitalinsights.supremeclients.com
SUMMARY:How clinical labs can confidently assess cancer-associated variants with real-world data and expert-curated genomic evidence
DESCRIPTION:Across various stages of the clinical oncology workflow\, from panel design to genomic testing and molecular tumor boards\, the identification and validation of actionable genomic alterations is critical. The advent of next-generation sequencing (NGS) has led to an exponential increase in the number of variants detected in tumor testing\, posing a challenge for clinical cancer genetics professionals seeking to confidently discern clinically relevant mutations that can guide patient care decisions.\n\nJoin Dr. Umadevi Thirumurthi\, Associate Director of Global Product Management for Oncology at QIAGEN Digital Insights as she discusses how the Human Somatic Mutation Database (HSMD)\, an expert-curated somatic variant database\, can enhance your clinical NGS workflow.\n\nAttendees will learn how HSMD:\n\nCan be used to design targeted panels\, streamline somatic variant analysis\, and support molecular tumor board decisions;\nProvides access to data from over 419\,00 real-world oncology cases and human-certified expert curation\nEnables users to effortlessly explore mutational characteristics across genes\, synthesize critical information from drug labels and professional guidelines\, investigate ongoing clinical trials\, and access comprehensive annotations for each observed variant
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-clinical-labs-can-confidently-assess-cancer-associated-variants-with-real-world-data-and-expert-curated-genomic-evidence/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1144_4_QDI_QCI_HSMD_GI1227547264_Full-resolution_59165-scaled-1.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231115T130000
DTEND;TZID=America/New_York:20231115T143000
DTSTAMP:20260404T211905
CREATED:20231109T061008Z
LAST-MODIFIED:20241024T182953Z
UID:10000707-1700053200-1700058600@staging.digitalinsights.supremeclients.com
SUMMARY:Easily process your FASTQ files
DESCRIPTION:Do you ever get stuck processing raw FASTQ data or cell matrix data from your RNA-seq\, scRNA-seq or other NGS assays using? Are you interested in creating a differential expression table that’s compatible with the QIAGEN Ingenuity Pathway Analysis (IPA) software you use? In this training\, you’ll learn how to use QIAGEN CLC Genomics Workbench to easily process your FASTQ files and generate differential expression tables without using command line tools. We’ll also explore how you can generate other desired outputs\, such as volcano plots\, heatmaps\, PCA/PCOA plots and more.  \nYou can delve into more information about QIAGEN CLC Genomics Workbench here:\nhttps://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-clc-genomics-workbench/ 
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/find-out-how-ipa-users-can-process-their-fastq-files/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1040_9_QDI_ICLC_GWBv21_Gi1223402761_16x9_Large-1200px_53601.jpg
END:VEVENT
END:VCALENDAR